{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T16:05:15Z","timestamp":1771430715454,"version":"3.50.1"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T00:00:00Z","timestamp":1768262400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T00:00:00Z","timestamp":1768262400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"DOI":"10.1007\/s00296-025-06069-x","type":"journal-article","created":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T10:26:26Z","timestamp":1768299986000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Tofacitinib treatment in a girl with localized scleroderma of the head and face: a case-based review"],"prefix":"10.1007","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3771-9356","authenticated-orcid":false,"given":"Agnieszka","family":"Gazda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8293-7993","authenticated-orcid":false,"given":"Iryna","family":"Naishtetik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-0135-1315","authenticated-orcid":false,"given":"Hanna","family":"Grabowska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-7348-1185","authenticated-orcid":false,"given":"Anna","family":"Wolszczak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-7888-8874","authenticated-orcid":false,"given":"Ma\u0142gorzata","family":"Gil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9718-0543","authenticated-orcid":false,"given":"Beata","family":"Ko\u0142odziejczyk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-6853-8564","authenticated-orcid":false,"given":"Olga","family":"Krasowicz-Towalska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2413-0083","authenticated-orcid":false,"given":"Piotr","family":"Gietka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,13]]},"reference":[{"issue":"6","key":"6069_CR1","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1097\/01.bor.0000245727.40630.c3","volume":"18","author":"RM Laxer","year":"2006","unstructured":"Laxer RM, Zulian F (2006) Localized scleroderma. Curr Opin Rheumatol 18(6):606\u201313. https:\/\/doi.org\/10.1097\/01.bor.0000245727.40630.c3","journal-title":"Curr Opin Rheumatol"},{"issue":"Suppl 1","key":"6069_CR2","doi-asserted-by":"publisher","first-page":"S48","DOI":"10.5152\/eurjrheumatol.2019.19183","volume":"7","author":"DH Glaser","year":"2020","unstructured":"Glaser DH, Schutt C, Schollaert-Fitch K, Torok K (2020) Linear scleroderma of the head - Updates in management of Parry Romberg syndrome and en coup de sabre: a rapid scoping review across subspecialties. Eur J Rheumatol 7(Suppl 1):S48-57. https:\/\/doi.org\/10.5152\/eurjrheumatol.2019.19183","journal-title":"Eur J Rheumatol"},{"issue":"7","key":"6069_CR3","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.63984","volume":"16","author":"EM Hariri","year":"2024","unstructured":"Hariri EM, Sellouti M, Ramdi H (2024) Oral manifestations of Parry-Romberg syndrome: a case report. Cureus 16(7):e63984. https:\/\/doi.org\/10.7759\/cureus.63984","journal-title":"Cureus"},{"key":"6069_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.yebeh.2021.108068","volume":"121","author":"AM Hixon","year":"2021","unstructured":"Hixon AM, Christensen E, Hamilton R, Drees C (2021) Epilepsy in Parry\u2013Romberg syndrome and linear scleroderma en coup de sabre: case series and systematic review including 140 patients. Epilepsy Behav 121:108068. https:\/\/doi.org\/10.1016\/j.yebeh.2021.108068","journal-title":"Epilepsy Behav"},{"issue":"8","key":"6069_CR5","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1002\/acr.21687","volume":"64","author":"SC Li","year":"2012","unstructured":"Li SC, Torok KS, Pope E, Dedeoglu F, Hong S, Jacobe HT et al (2012) Development of consensus treatment plans for juvenile localized scleroderma. Arthritis Care Res (Hoboken). 64(8):1175\u201385. https:\/\/doi.org\/10.1002\/acr.21687","journal-title":"Arthritis Care Res (Hoboken)."},{"issue":"8","key":"6069_CR6","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1136\/annrheumdis-2018-214668","volume":"78","author":"F Zulian","year":"2019","unstructured":"Zulian F, Culpo R, Sperotto F, Anton J, Avcin T, Baildam EM et al (2019) Consensus-based recommendations for the management of juvenile localised scleroderma. Ann Rheum Dis. 78(8):1019\u201324. https:\/\/doi.org\/10.1136\/annrheumdis-2018-214668","journal-title":"Ann Rheum Dis."},{"issue":"1","key":"6069_CR7","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s12969-019-0343-7","volume":"17","author":"SC Li","year":"2019","unstructured":"Li SC, Fuhlbrigge RC, Laxer RM, Pope E, Ibarra MF, Stewart K et al (2019) Developing comparative effectiveness studies for a rare, understudied pediatric disease: lessons learned from the CARRA juvenile localized scleroderma consensus treatment plan pilot study. Pediatr Rheumatol Online J. 17(1):43. https:\/\/doi.org\/10.1186\/s12969-019-0343-7","journal-title":"Pediatr Rheumatol Online J."},{"issue":"8","key":"6069_CR8","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.3899\/jrheum.190367","volume":"47","author":"SC Li","year":"2019","unstructured":"Li SC, Torok KS, Rabinovich CE, Dedeoglu F, Becker ML, Ferguson PJ et al (2019) Initial results from a pilot comparative effectiveness study of 3 methotrexate-based consensus treatment plans for juvenile localized scleroderma. J Rheumatol. 47(8):1242\u201352. https:\/\/doi.org\/10.3899\/jrheum.190367","journal-title":"J Rheumatol."},{"issue":"3","key":"6069_CR9","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1111\/ddg.15340","volume":"22","author":"A Kreuter","year":"2024","unstructured":"Kreuter A, Moinzadeh P, Kinberger M, Horneff G, Worm M, Werner RN et al (2024) S2k guideline: diagnosis and therapy of localized scleroderma. J Dtsch Dermatol Ges. 22(3):439\u201355. https:\/\/doi.org\/10.1111\/ddg.15340","journal-title":"J Dtsch Dermatol Ges."},{"key":"6069_CR10","doi-asserted-by":"publisher","DOI":"10.2340\/actadv.v103.4805","volume":"103","author":"JC Tang","year":"2023","unstructured":"Tang JC, Zheng WY, Han GM, Liu S, Yang B (2023) Successful treatment of paediatric morphea with tofacitinib. Acta Derm Venereol 103:adv4805. https:\/\/doi.org\/10.2340\/actadv.v103.4805","journal-title":"Acta Derm Venereol"},{"issue":"1","key":"6069_CR11","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1111\/1346-8138.16980","volume":"51","author":"Q Zou","year":"2023","unstructured":"Zou Q, Wei R, Yao Z, Li H (2023) Successful treatment with baricitinib of linear morphea following the lines of Blaschko mimicking lichen striatus. J Dermatol 51(1):115\u20139. https:\/\/doi.org\/10.1111\/1346-8138.16980","journal-title":"J Dermatol"},{"issue":"4","key":"6069_CR12","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1111\/pde.16025","volume":"42","author":"G Rabinowitz","year":"2025","unstructured":"Rabinowitz G, Gulati N, Khattri S, Fenner J (2025) Localized morphea in a pediatric patient successfully treated with topical ruxolitinib. Pediatr Dermatol 42(4):1306\u20137. https:\/\/doi.org\/10.1111\/pde.16025","journal-title":"Pediatr Dermatol"},{"issue":"3","key":"6069_CR13","doi-asserted-by":"publisher","first-page":"533","DOI":"10.55730\/1300-0144.6000","volume":"55","author":"S Sener","year":"2025","unstructured":"Sener S, Sener YZ, Batu ED, Sari A, Akdo\u011fan A (2025) Janus kinase inhibitors in localized scleroderma: a systematic literature review. Turk J Med Sci 55(3):533\u20139. https:\/\/doi.org\/10.55730\/1300-0144.6000","journal-title":"Turk J Med Sci"},{"issue":"30","key":"6069_CR14","doi-asserted-by":"publisher","DOI":"10.3346\/jkms.2024.39.e225","volume":"39","author":"IC Benlidayi","year":"2024","unstructured":"Benlidayi IC, Gupta L (2024) CAse-BAsed REview sTandards (CABARET): considerations for authors, reviewers, and editors. J Korean Med Sci 39(30):e225. https:\/\/doi.org\/10.3346\/jkms.2024.39.e225","journal-title":"J Korean Med Sci"},{"key":"6069_CR15","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/719685","volume":"2012","author":"TN Amaral","year":"2012","unstructured":"Amaral TN, Marques Neto JF, Lapa AT, Peres FA, Guirau CR, Appenzeller S (2012) Neurologic involvement in scleroderma en coup de sabre. Autoimmune Dis 2012:719685. https:\/\/doi.org\/10.1155\/2012\/719685","journal-title":"Autoimmune Dis"},{"issue":"4","key":"6069_CR16","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1097\/MOP.0000000000000784","volume":"31","author":"AG Pe\u00f1a-Romero","year":"2019","unstructured":"Pe\u00f1a-Romero AG, Garc\u00eda-Romero MT (2019) Diagnosis and management of linear scleroderma in children. Curr Opin Pediatr 31(4):482\u201390. https:\/\/doi.org\/10.1097\/MOP.0000000000000784","journal-title":"Curr Opin Pediatr"},{"issue":"1","key":"6069_CR17","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1177\/2397198319864275","volume":"5","author":"W Wang","year":"2019","unstructured":"Wang W, Bhattacharyya S, Marangoni RG, Carns M, Dennis-Aren K, Yeldandi A et al (2019) The JAK\/STAT pathway is activated in systemic sclerosis and is effectively targeted by tofacitinib. J Scleroderma Relat Disord. 5(1):40\u201350. https:\/\/doi.org\/10.1177\/2397198319864275","journal-title":"J Scleroderma Relat Disord."},{"issue":"10","key":"6069_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2022.103168","volume":"21","author":"C Moriana","year":"2022","unstructured":"Moriana C, Moulinet T, Jaussaud R, Decker P (2022) JAK inhibitors and systemic sclerosis: a systematic review of the literature. Autoimmun Rev 21(10):103168. https:\/\/doi.org\/10.1016\/j.autrev.2022.103168","journal-title":"Autoimmun Rev"},{"issue":"6","key":"6069_CR19","doi-asserted-by":"publisher","DOI":"10.1111\/dth.15469","volume":"35","author":"SA McGaugh","year":"2022","unstructured":"McGaugh SA, Kallis P, De Benedetto A, Thomas RM (2022) Janus kinase inhibitors for treatment of morphea and systemic sclerosis: a literature review. Dermatol Ther 35(6):e15469. https:\/\/doi.org\/10.1111\/dth.15469","journal-title":"Dermatol Ther"},{"issue":"5","key":"6069_CR20","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.jdcr.2017.12.003","volume":"4","author":"SR Kim","year":"2018","unstructured":"Kim SR, Charos A, Damsky W, Heald P, Girardi M, King BA (2018) Treatment of generalized deep morphea and eosinophilic fasciitis with the Janus kinase inhibitor tofacitinib. JAAD Case Rep 4(5):443\u20135. https:\/\/doi.org\/10.1016\/j.jdcr.2017.12.003","journal-title":"JAAD Case Rep"},{"key":"6069_CR21","unstructured":"Osminina M, Podchernyaeva N, Seraya V, Kurbanova S, Batureva O, Chebusheva S, et al. Efficacy and tolerability of Janus kinase inhibitor tofacitinib in juvenile linear scleroderma: case series of 5 patients. Georgian Med News. 2025;(358):26\u201330."},{"issue":"8","key":"6069_CR22","doi-asserted-by":"publisher","DOI":"10.1111\/1756-185X.15295","volume":"27","author":"L Colussi","year":"2024","unstructured":"Colussi L, Dagri A, Pastore S, Tommasini A, Pin A, Taddio A (2024) Effect of the Janus kinase inhibitor tofacitinib in the treatment of juvenile scleroderma: a single-center experience. Int J Rheum Dis 27(8):e15295. https:\/\/doi.org\/10.1111\/1756-185X.15295","journal-title":"Int J Rheum Dis"},{"key":"6069_CR23","doi-asserted-by":"publisher","unstructured":"Soh HJ, Samuel C, Heaton V, Renton WD, Cox A, Munro J. Challenges in the diagnosis and treatment of disabling pansclerotic morphea of childhood: case-based review. Rheumatol Int. 2019;39(5):933\u2009\u2212\u200941. https:\/\/doi.org\/10.1007\/s00296-019-\u200c","DOI":"10.1007\/s00296-019-\u200c"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-025-06069-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00296-025-06069-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-025-06069-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T15:14:11Z","timestamp":1771427651000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00296-025-06069-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,13]]},"references-count":23,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,1]]}},"alternative-id":["6069"],"URL":"https:\/\/doi.org\/10.1007\/s00296-025-06069-x","relation":{},"ISSN":["1437-160X"],"issn-type":[{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,13]]},"assertion":[{"value":"8 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that there is no conflict of interest to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Written informed consent for publication of the clinical details and accompanying images was obtained from the patient\u2019s parents, in accordance with the Declaration of Helsinki and COPE best practice guidelines.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}],"article-number":"32"}}